<?php include 'header.php'; ?>
<style>
span{
    font-weight: bold;
}
</style>
<div class="container">
    <div class="mt-5 mb-2">
        <h5 style="color: #046C94;">Scientific Program</h5>
    </div>
    <div>
        <div class="row">
            <div class="col-3">
                <p>0730–08:30   <br>
                Course Director</p>

            </div>
            <div class="col-9">
                <p>Session 1: Master class: Prostate Biopsy   <br>
                Prof Henry Ho</p>
            </div>
        </div>
        <div class="row">
            <div class="col-3">
                <p>08:30-09:00 <br>
                09:00– 11:00</p>
            </div>
            <div class="col-9">
                <p>Registraion  <br>
                <span>Session 1: </span> <br>
                   <span> Controversies in Prostate Cancer Management: 1 </span><br>
                    DRE in PCA is it mandatory in modern age? <br>
                    PSA screening and next generation biomarkers: where we are. <br>
                    What is the role of PSMA-PET CT in the management of prostate cancer - should treatment decisions be
                    made based on this imaging modality? <br>
                    High risk localized vs locally advanced Cap: are they the same disease? <br>
                    Surgery v RT (+ Brachy) in high risk localized AND locally advanced prostate cancer <br>
                    Should Docetaxel / Abiraterone be given to men with high risk <br>
                    localized / locally advanced disease in addition to RT <br> <br>

                    <span> Controversies in Prostate Cancer Management: 2</span> <br>
                    The role of primary lymphadenectomy in prostate cancer - Is less more or is more more? (extent of
                    ePLND discussion) <br>
                    Role of Radical Prostatectomy in Oligometastatic Disease
                    Does Local Treatment in Advanced Prostate Cancer Truly Reduce
                    Morbidity and Pelvic Complications from Local Disease?
                    Locally advanced Prostate cancer Salvage RP Vs Salvage RT
                    What is the role of PSMA-PET CT in the management of prostate cancer - should treatment decisions be
                    made based on this imaging modality? <br> <br>

                    <span>Controversies in Prostate Cancer Management: 3</span> <br>
                    Does non-metastatic castrate resistant prostate cancer truly exist?
                    What is the optimum management of Hormone sensitive metastatic prostate cancer?
                    What is the optimum management of Castrate resistant metastatic prostate cancer?
                    How should bone health be addressed for men receiving both short- and long-term ADT?
                    Should Docetaxel / Abiraterone be given to men with high risk localized / locally advanced disease
                    in addition to RTScientific Program <br>

                    Is there a role for neoadjuvant / adjuvant Docetaxel with
                    prostatectomy for high risk localized / locally advanced prostate cancer
                </p>
            </div>
        </div>
        <div class="row">
            <div class="col-3">
                <p>
                    11:00– 11:30 <br>
                    11:30 – 13:00 <br>
                    13:00 – 14:00 <br>
                    14:00 – 15:00
                </p>
            </div>
            <div class="col-9">
                <p>
                    <span>Tea</span> <br>
                    <span>Controversies in Prostate Cancer Management: Laurence Klotz hour </span><br>
                    <span>Lunch with Video </span><br>
                    <span>Controversies in Kidney Cancer Management</span> <br>
                    Should the CARMENA trial change how we perform cytoreductive radical nephrectomy?
                    Should TKIs/Immunotherapy be used to downstage tumours to allow partial nephrectomy in renal cell
                    carcinoma?
                    The small renal mass in the elderly - are we managing the scan or the patient?
                    Is there a role for adjuvant therapy first-line metastatic cancer - IO + IO vs IO + VEGF
                    Systemic therapy for non clear cell RCC
                    Biomarker driven metastatic RCC treatment

                </p>
            </div>
        </div>
        <div class="row">
            <div class="col-3">
                <p>15:00 – 16:00</p>
            </div>
            <div class="col-9">
                <p> <span>Controversies in Bladder Cancer Management</span> <br>
                    Two Sides of The Coin - The T0 Radial Cystectomy: Curse or Cure?
                    Is it safe to manage the complete chemo responder in muscle invasive bladder cancer with
                    surveillance?
                    Immunotherapy in NMIBC - Hype or Reason and Are we ready?
                    Does Ureteroscopy as a diagnostic procedure in UTUC lead to increased bladder cancer recurrence
                    rates?
                    Should all patients with MIBC be offered bladder preservation with salvage cystectomy?
                </p>
            </div>
        </div>

        <div class="row">
            <div class="col-3">
                <p>
                    16:00 – 16:15 <br>
                    16:15 – 17:15
                </p>
            </div>
            <div class="col-9">
                <p>  <span>Tea </span>  <br>
                   <span> Controversies in Testicular Cancer Management </span> <br>
                    Optimal management for tumour marker -ve Stage 2 NSGCT: chemo vs RPLND
                    Carboplatin vs cisplatin containing chemo for stage 4 seminoma
                    Intensifies upfront chemo for poor prognosis NSGCT optimal treatment of mediastinal GCT
                    Management of patients with bone and brain mets - what to do after chemo (? tumour directed therapy)
                </p>
            </div>
        </div>
    </div>

</div>


<?php include 'footer.php'; ?>